Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
Status:
Recruiting
Trial end date:
2027-10-24
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the effectiveness of telitacicept in pediatric patients
with frequently relapsing or steroid dependent nephrotic syndrome within the 52-week
follow-up.
Phase:
Phase 3
Details
Lead Sponsor:
The Children's Hospital of Zhejiang University School of Medicine